Robert H. Vonderheide was appointed to a second five-year term as director of the Abramson Cancer Center at the University of Pennsylvania. He will continue in his roles as vice president for cancer programs for the University of Pennsylvania Health System and vice dean for cancer programs in Penn’s Perelman School of Medicine.
The Cancer Letter has covered—and will continue to cover—all the ways in which the current administration is fundamentally reshaping cancer research in the U.S. But this week, The Cancer Letter and the podcast focused on a patient story.
